乳房再造中组织扩张器丢失后的再造趋势
该回顾性研究在单中心筛查674例组织扩张器乳房再造(TEBR)患者,60例(8.9%)因感染或皮肤坏死需取出扩张器。取出后31例未完成再造,29例完成再造;未完成组平均BMI显著更高(32.61±8.88 vs 28.69±5.84;P=0.049),距机构更远趋势显著(P=0.052)。
要点
- TEBR患者中8.9%(60/674)因感染或皮肤坏死需取出组织扩张器。
- 取出后未完成再造者平均BMI显著高于完成再造者(32.61±8.88 vs 28.69±5.84;P=0.049)。
- 完成再造者中,二次TEBR组与自体重建组并发症相关入院次数差异显著(1.11±0.323 vs 1.55±0.688;P=0.029)。
核心结论
- 数据展示了初始组织扩张器丢失后乳房再造决策的趋势,并阐明了与患者选择不同再造方案相关的因素。
- 作者认为需要在更大队列中进一步研究以明确选择不同再造路径的具体原因。
研究设计与样本
- 回顾性研究,单中心,纳入乳房切除术后即刻TEBR并随后发生组织扩张器丢失的患者。
- 排除乳房切除术后自体重建或TEBR成功的患者;随访平均7年,最短2年,最长13年。
- 初始筛查674例TEBR患者,其中60例(8.9%)因感染或皮肤坏死需取出组织扩张器。
主要发现
- 60例取出扩张器患者中,31例(组1)在初始扩张器丢失后未完成再造,29例(组2)完成了TEBR或自体重建。
- 组1平均BMI显著高于组2(32.61±8.88 vs 28.69±5.84;P=0.049)。
- 组1居住地距机构更远,趋势接近显著(P=0.052);两组其余人口学特征无显著差异。
- 组2中18例接受二次TEBR(组2a),11例接受自体重建(组2b)。
- 组2b平均并发症相关入院次数显著多于组2a(1.11±0.323 vs 1.55±0.688;P=0.029)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Tissue-expander breast reconstruction (TEBR) is a common method of reconstruction after mastectomy but may result in complications that may necessitate removal. Although complications in TEBR have been well studied, there is a paucity of data regarding outcomes after tissue-expander loss. In this study, we examine the eventual reconstructive pathways and associated factors of patients who required tissue-expander removal after infection. METHODS: This retrospective study examines patients undergoing breast reconstruction at a single institution. Patients included underwent mastectomy, immediate TEBR, and subsequent tissue-expander loss. Patients who underwent autologous reconstruction after mastectomy or had successful TEBR were excluded. Patients were followed for an average of 7 years, with a minimum of 2 years and a maximum of 13 years. RESULTS: A total of 674 TEBR patients were initially screened, of which 60 patients (8.9%) required tissue-expander removal because of infection or skin necrosis. Thirty-one of these patients (group 1) did not complete reconstruction after initial tissue-expander loss, whereas the remaining 29 patients (group 2) underwent either TEBR or autologous reconstruction after tissue-expander loss. Group 1 had a significantly higher mean body mass index than group 2 (32.61 ± 8.88 vs 28.69 ± 5.84; P = 0.049) and also lived further away from our institution than group 2 (P = 0.052), which trended toward significance. There were otherwise no significant differences in demographics between the 2 groups.Among the 29 patients in group 2, 18 patients underwent a second TEBR (group 2a), and 11 patients underwent autologous reconstruction (group 2b). Patients in group 2b had a significantly greater mean number of complication related admissions (1.11 ± 0.323 vs 1.55 ± 0.688; P = 0.029) and also had higher occurrence of postmastectomy radiation therapy (16.7% vs 45.5%; P = 0.092), although this was not significant. There were otherwise no differences between the 2 groups. CONCLUSION: Our data demonstrate the trends in breast reconstruction decision making after initial tissue-expander loss. This study elucidates the factors associated with patients who undergo different reconstructive options. Further work is needed to delineate the specific reasons between the decision to pursue different reconstructive pathways among a larger cohort of patients.
引用
- Ghosh K, Marquez J, Niu E, et al. Reconstructive Trends After Tissue-Expander Loss in Breast Reconstruction. Ann Plast Surg. 2022. PMID: 35276711. doi:10.1097/SAP.0000000000003127
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。